Nona Darou Pars

Nona Darou Pars is an Iranian pharmaceutical company specializing in the development and manufacturing of high-tech biotechnological products and biosimilars. The company focuses on therapeutic areas such as endocrinology, oncology, and rheumatology, with a portfolio that includes treatments for osteoporosis and infertility. Nona Darou Pars operates advanced manufacturing facilities that adhere to international GMP standards to ensure the quality of its biologic medicines. By leveraging local expertise in biotechnology, the company aims to provide affordable access to complex therapies within the Middle Eastern market. Their product line features several key biosimilars, including versions of teriparatide, denosumab, and follitropin alfa.